X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (7) 7
cancer (6) 6
chemotherapy (6) 6
index medicus (6) 6
humans (4) 4
aged (3) 3
cancer therapies (3) 3
care and treatment (3) 3
female (3) 3
male (3) 3
middle aged (3) 3
research (3) 3
adult (2) 2
analysis (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antiemetics (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apf530 (2) 2
bevacizumab (2) 2
carboplatin - administration & dosage (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
chemotherapy-induced nausea and vomiting (2) 2
comparative analysis (2) 2
drug therapy (2) 2
extended-release (2) 2
granisetron (2) 2
guideline update (2) 2
health care sciences & services (2) 2
immunotherapy (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
medical research (2) 2
medicine & public health (2) 2
nausea (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
nursing (2) 2
nursing management/nursing research (2) 2
oncology, experimental (2) 2
ondansetron (2) 2
pain medicine (2) 2
pembrolizumab (2) 2
pemetrexed - administration & dosage (2) 2
rehabilitation (2) 2
rehabilitation medicine (2) 2
respiratory system (2) 2
subcutaneous (2) 2
vomiting (2) 2
1st-line treatment (1) 1
5-ht3 receptor antagonist (1) 1
acquired-resistance (1) 1
adaptive resistance (1) 1
antibodies (1) 1
anticancer agents (1) 1
antiemetics - therapeutic use (1) 1
antimicrobial resistance (1) 1
antimitotic agents (1) 1
apoptosis (1) 1
bacteria (1) 1
bacterial infections - drug therapy (1) 1
bacterial infections - etiology (1) 1
berlin (1) 1
bevacizumab - administration & dosage (1) 1
biomarker (1) 1
blood-stream infections (1) 1
calreticulin exposure (1) 1
cancer immune phenotype (1) 1
cancer immune responsiveness (1) 1
cancer patients (1) 1
carboplatin (1) 1
carcinoma (1) 1
causes of (1) 1
cell lung-cancer (1) 1
cell-death (1) 1
cisplatin (1) 1
clinical trials (1) 1
cohort studies (1) 1
colorectal cancer (1) 1
combination (1) 1
combination therapy (1) 1
communicable diseases (1) 1
community support (1) 1
comparative studies (1) 1
complications and side effects (1) 1
conferences, meetings and seminars (1) 1
controlled-trial (1) 1
current clinical issues (1) 1
cytotoxicity (1) 1
delayed emesis (1) 1
delayed-action preparations - therapeutic use (1) 1
docetaxel (1) 1
double-blind (1) 1
double-blind method (1) 1
drug dosages (1) 1
drug resistance (1) 1
erlotinib (1) 1
escherichia-coli (1) 1
ethnicity (1) 1
gefitinib (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1497 - 1508
Journal Article
Journal of the American Society of Cytopathology, ISSN 2213-2945, 2013, Volume 2, Issue 1, pp. S59 - S59
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 3/2015, Volume 23, Issue 3, pp. 723 - 732
Journal Article
Future Oncology, ISSN 1479-6694, 09/2015, Volume 11, Issue 18, pp. 2541 - 2551
Background: APF530 is a novel sustained-release formulation of granisetron. In a Phase III trial, APF530 500 mg was noninferior to palonosetron 0.25 mg in... 
subcutaneous | granisetron | APF530 | cancer | chemotherapy-induced nausea and vomiting | extended-release | INDUCED NAUSEA | GUIDELINE UPDATE | PHASE-III | PREVENTION | ONDANSETRON | TRIAL | ONCOLOGY | DOUBLE-BLIND
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2019, Volume 14, Issue 3, pp. 553 - 559
Introduction: Anti-EGFR agents are standard treatments for patients with EGFR-mutant advanced NSCLC. The feasibility of combining erlotinib or gefitinib with... 
Pembrolizumab | Erlotinib | NSCLC | Combination therapy | Gefitinib | CELL LUNG-CANCER | OSIMERTINIB | ONCOLOGY | RESPIRATORY SYSTEM | PD-1 | CHEMOTHERAPY
Journal Article
Journal Article
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 05/2009, Volume 5, Issue 3, pp. 130 - 133
New agents and studies have demonstrated benefit in improving antiemetic therapy. Incorporating evidence-based guideline recommendations and appropriate emesis... 
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 05/2019, Volume 7, Issue 1, pp. 131 - 23
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 07/2019, Volume 7, Issue 1, pp. 167 - 2
Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list. 
Conferences, meetings and seminars | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.